These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17920217)

  • 1. Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion.
    Fukuda M; Miller DA; Peppas NA; McGinity JW
    Int J Pharm; 2008 Feb; 350(1-2):188-96. PubMed ID: 17920217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the preparation method on the physical-chemical properties of ketoprofen-cyclodextrin-phosphatidylcholine ternary systems.
    Cirri M; Maestrelli F; Mennini N; Mura P
    J Pharm Biomed Anal; 2009 Dec; 50(5):690-4. PubMed ID: 19097721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical-chemical characterization of binary and ternary systems of ketoprofen with cyclodextrins and phospholipids.
    Cirri M; Maestrelli F; Mennini N; Mura P
    J Pharm Biomed Anal; 2009 Dec; 50(5):683-9. PubMed ID: 19095391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
    Onyeji CO; Omoruyi SI; Oladimeji FA
    Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.
    Tho I; Liepold B; Rosenberg J; Maegerlein M; Brandl M; Fricker G
    Eur J Pharm Sci; 2010 Apr; 40(1):25-32. PubMed ID: 20172027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion.
    Albers J; Alles R; Matthée K; Knop K; Nahrup JS; Kleinebudde P
    Eur J Pharm Biopharm; 2009 Feb; 71(2):387-94. PubMed ID: 18951978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
    Cirri M; Bragagni M; Mennini N; Mura P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicability of (SBE)7m-beta-CD in controlled-porosity osmotic pump tablets (OPTs).
    Okimoto K; Tokunaga Y; Ibuki R; Irie T; Uekama K; Rajewski RA; Stella VJ
    Int J Pharm; 2004 Nov; 286(1-2):81-8. PubMed ID: 15501004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated ketoprofen release from polymeric matrices: importance of the homogeneity/heterogeneity of excipient distribution.
    Gue E; Willart JF; Muschert S; Danede F; Delcourt E; Descamps M; Siepmann J
    Int J Pharm; 2013 Nov; 457(1):298-307. PubMed ID: 24076398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
    Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
    Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion complex of trimethoprim with beta-cyclodextrin.
    Li N; Zhang YH; Wu YN; Xiong XL; Zhang YH
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):824-9. PubMed ID: 16011886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of beta-cyclodextrin and its water-soluble derivatives on in vitro drug transport across rat intestinal epithelium.
    Zheng Y; Zuo Z; Chow AH
    Int J Pharm; 2006 Feb; 309(1-2):123-8. PubMed ID: 16359834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of dissolution behavior for poorly water-soluble drug by application of cyclodextrin in extrusion process: comparison between melt extrusion and wet extrusion.
    Yano H; Kleinebudde P
    AAPS PharmSciTech; 2010 Jun; 11(2):885-93. PubMed ID: 20496019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on solubility and hypoglycemic activity of gliclazide beta-cyclodextrin-hydroxypropylmethylcellulose complexes.
    Aggarwal S; Singh PN; Mishra B
    Pharmazie; 2002 Mar; 57(3):191-3. PubMed ID: 11933849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclodextrins.
    Stella VJ; He Q
    Toxicol Pathol; 2008 Jan; 36(1):30-42. PubMed ID: 18337219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films.
    Crowley MM; Fredersdorf A; Schroeder B; Kucera S; Prodduturi S; Repka MA; McGinity JW
    Eur J Pharm Sci; 2004 Aug; 22(5):409-18. PubMed ID: 15265510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a sulfobutyl ether beta-cyclodextrin as a solubilizing/stabilizing agent for several drugs.
    Ueda H; Ou D; Endo T; Nagase H; Tomono K; Nagai T
    Drug Dev Ind Pharm; 1998 Sep; 24(9):863-7. PubMed ID: 9876538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.